Sugarman, Jeremy https://orcid.org/0000-0001-7022-8332
Article History
Received: 20 May 2025
Accepted: 20 May 2025
First Online: 27 May 2025
Disclosure and competing interests statement
: The author is a consultant to Merck KGaA and Merck and a member of Aspen Neurosciences Clinical Advisory Committee. He is also a member of the International Society for Stem Cell Research’s Ethics and Policy Committees and Editorial Board Member and Special Advisor for bioethics for EMBO reports . The views expressed in this paper are the author’s own.